Total Payments
$172,742
2024 Payments
$2,401
Companies
49
Transactions
714
Medicare Patients
26,541
Medicare Billing
$2.3M
Payment Breakdown by Category
Other$138,825 (80.4%)
Food & Beverage$12,825 (7.4%)
Research$7,132 (4.1%)
Consulting$6,175 (3.6%)
Travel$4,641 (2.7%)
Education$3,145 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $138,825 | 43 | 80.4% |
| Food and Beverage | $12,825 | 628 | 7.4% |
| Unspecified | $7,132 | 11 | 4.1% |
| Consulting Fee | $6,175 | 1 | 3.6% |
| Travel and Lodging | $4,641 | 18 | 2.7% |
| Education | $3,145 | 13 | 1.8% |
Payments by Type
General
$165,610
703 transactions
Research
$7,132
8 transactions
Ownership
$0
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $147,780 | 194 | $0 (2024) |
| Glenmark Pharmaceuticals Inc. | $7,132 | 8 | $0 (2017) |
| Intuitive Surgical, Inc. | $3,432 | 4 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $3,015 | 21 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,630 | 85 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,357 | 69 | $0 (2024) |
| Olympus Corporation of the Americas | $1,157 | 9 | $0 (2017) |
| Grifols USA, LLC | $1,001 | 57 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $821.73 | 30 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $626.27 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,401 | 102 | JAZZ PHARMACEUTICALS INC. ($321.15) |
| 2023 | $28,980 | 98 | GlaxoSmithKline, LLC. ($24,142) |
| 2022 | $33,001 | 109 | GlaxoSmithKline, LLC. ($31,646) |
| 2021 | $28,677 | 65 | GlaxoSmithKline, LLC. ($27,807) |
| 2020 | $32,730 | 62 | GlaxoSmithKline, LLC. ($31,964) |
| 2019 | $33,407 | 88 | GlaxoSmithKline, LLC. ($31,605) |
| 2018 | $4,040 | 77 | Teva Pharmaceuticals USA, Inc. ($2,751) |
| 2017 | $9,506 | 113 | Glenmark Pharmaceuticals Inc. ($7,132) |
All Payment Transactions
714 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $38.96 | General |
| Category: NEUROLOGY | ||||||
| 12/17/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Pulmonology | ||||||
| 12/16/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Immunology | ||||||
| 12/09/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/05/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: PULMONOLOGY | ||||||
| 11/26/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: Pulmonology | ||||||
| 11/20/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: NEUROLOGY | ||||||
| 11/19/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $34.64 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $33.80 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $33.84 | General |
| Category: Airway Clearance Device | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: PULMONOLOGY | ||||||
| 10/21/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $33.75 | General |
| Category: Pulmonology | ||||||
| 10/17/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: NEUROLOGY | ||||||
| 10/14/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| GSP304-201 | Glenmark Pharmaceuticals Inc. | $7,132 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 5,366 | 7,530 | $1.1M | $444,603 |
| 2022 | 20 | 7,008 | 10,143 | $1.5M | $603,068 |
| 2021 | 20 | 7,654 | 11,629 | $1.6M | $727,961 |
| 2020 | 22 | 6,513 | 9,215 | $1.3M | $570,426 |
Total Patients
26,541
Total Services
38,517
Medicare Billing
$2.3M
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 960 | 1,802 | $360,400 | $173,821 | 48.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 240 | 654 | $147,150 | $61,498 | 41.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 274 | 306 | $107,100 | $41,989 | 39.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 230 | 510 | $82,445 | $31,863 | 38.6% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 630 | 645 | $64,500 | $24,191 | 37.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 734 | 842 | $71,570 | $23,205 | 32.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 579 | 590 | $50,150 | $23,010 | 45.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 184 | 184 | $44,160 | $22,707 | 51.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 26 | 176 | $17,600 | $10,273 | 58.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 42 | 49 | $12,250 | $6,850 | 55.9% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 677 | 784 | $27,440 | $5,304 | 19.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 27 | 27 | $8,100 | $4,456 | 55.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 160 | 244 | $8,540 | $2,649 | 31.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 89 | 96 | $3,360 | $1,951 | 58.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 28 | $4,200 | $1,899 | 45.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 142 | 205 | $5,125 | $1,847 | 36.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 16 | 16 | $2,480 | $1,677 | 67.6% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 14 | 16 | $8,800 | $1,579 | 17.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 44 | 45 | $13,500 | $946.36 | 7.0% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 19 | 19 | $7,600 | $650.56 | 8.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 59 | 59 | $5,900 | $538.82 | 9.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 59 | 59 | $5,015 | $462.84 | 9.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 58 | 58 | $4,930 | $395.01 | 8.0% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 11 | 11 | $5,500 | $376.64 | 6.8% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 19 | 19 | $1,235 | $231.84 | 18.8% |
About Dr. Dany Obeid, MD
Dr. Dany Obeid, MD is a Sleep Medicine healthcare provider based in Daytona Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1841336310.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dany Obeid, MD has received a total of $172,742 in payments from pharmaceutical and medical device companies, with $2,401 received in 2024. These payments were reported across 714 transactions from 49 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($138,825).
As a Medicare-enrolled provider, Obeid has provided services to 26,541 Medicare beneficiaries, totaling 38,517 services with total Medicare billing of $2.3M. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Daytona Beach, FL
- Active Since 01/30/2007
- Last Updated 01/19/2021
- Taxonomy Code 207RS0012X
- Entity Type Individual
- NPI Number 1841336310
Products in Payments
- TRELEGY ELLIPTA (Drug) $109,088
- ION (Device) $3,000
- CINQAIR (Drug) $2,950
- Olympus EBUS Bronchoscopes (Device) $1,157
- NUCALA (Biological) $764.53
- OFEV (Drug) $677.42
- XYWAV (Drug) $658.95
- GLASSIA (Biological) $653.03
- Prolastin-C Liquid (Biological) $623.31
- DUPIXENT (Biological) $486.96
- Da Vinci Surgical System (Device) $432.43
- TEZSPIRE (Biological) $391.16
- Prolastin-C (Biological) $377.54
- SMARTVEST (Device) $304.97
- STIOLTO RESPIMAT (Drug) $273.92
- Esbriet (Biological) $253.37
- FASENRA (Biological) $249.12
- DUPIXENT (Drug) $228.89
- FASENRA (Drug) $220.33
- BREZTRI (Drug) $209.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.